nodes	percent_of_prediction	percent_of_DWPC	metapath
Suprofen—UGT1A1—hematologic cancer	0.263	1	CbGaD
Suprofen—Ibuprofen—Procarbazine—hematologic cancer	0.178	0.656	CrCrCtD
Suprofen—Ibuprofen—Melphalan—hematologic cancer	0.0937	0.344	CrCrCtD
Suprofen—PTGS2—Lenalidomide—hematologic cancer	0.0397	0.116	CbGbCtD
Suprofen—UGT1A1—Nilotinib—hematologic cancer	0.0269	0.0785	CbGbCtD
Suprofen—UGT2B7—Epirubicin—hematologic cancer	0.022	0.0642	CbGbCtD
Suprofen—PTGS2—Thalidomide—hematologic cancer	0.0212	0.0618	CbGbCtD
Suprofen—PTGS1—Bortezomib—hematologic cancer	0.0205	0.0599	CbGbCtD
Suprofen—UGT1A1—Irinotecan—hematologic cancer	0.0185	0.054	CbGbCtD
Suprofen—PTGS1—Thalidomide—hematologic cancer	0.0179	0.0522	CbGbCtD
Suprofen—PTGS1—Ifosfamide—hematologic cancer	0.0157	0.0459	CbGbCtD
Suprofen—PTGS1—Imatinib—hematologic cancer	0.015	0.0439	CbGbCtD
Suprofen—UGT1A1—Etoposide—hematologic cancer	0.0148	0.0432	CbGbCtD
Suprofen—PTGS2—Triamcinolone—hematologic cancer	0.0147	0.0428	CbGbCtD
Suprofen—CYP2C9—Bexarotene—hematologic cancer	0.0135	0.0393	CbGbCtD
Suprofen—PTGS2—Betamethasone—hematologic cancer	0.0126	0.0367	CbGbCtD
Suprofen—CYP2C9—Idarubicin—hematologic cancer	0.0112	0.0326	CbGbCtD
Suprofen—PTGS2—Cisplatin—hematologic cancer	0.00907	0.0265	CbGbCtD
Suprofen—PTGS2—Etoposide—hematologic cancer	0.00891	0.026	CbGbCtD
Suprofen—CYP2C9—Bortezomib—hematologic cancer	0.00827	0.0241	CbGbCtD
Suprofen—PTGS1—Etoposide—hematologic cancer	0.00753	0.022	CbGbCtD
Suprofen—PTGS2—Dexamethasone—hematologic cancer	0.00733	0.0214	CbGbCtD
Suprofen—CYP2C9—Thalidomide—hematologic cancer	0.0072	0.021	CbGbCtD
Suprofen—CYP2C9—Teniposide—hematologic cancer	0.00687	0.02	CbGbCtD
Suprofen—CYP2C9—Ifosfamide—hematologic cancer	0.00634	0.0185	CbGbCtD
Suprofen—CYP2C9—Imatinib—hematologic cancer	0.00606	0.0177	CbGbCtD
Suprofen—CYP2C9—Nilotinib—hematologic cancer	0.0055	0.0161	CbGbCtD
Suprofen—CYP2C9—Cisplatin—hematologic cancer	0.00308	0.00899	CbGbCtD
Suprofen—PTGS2—ovarian follicle—hematologic cancer	0.00279	0.359	CbGeAlD
Suprofen—CYP2C9—Dexamethasone—hematologic cancer	0.00249	0.00727	CbGbCtD
Suprofen—UGT1A1—hematopoietic system—hematologic cancer	0.000918	0.118	CbGeAlD
Suprofen—UGT1A1—blood—hematologic cancer	0.000608	0.0782	CbGeAlD
Suprofen—UGT2B7—testis—hematologic cancer	0.000592	0.0761	CbGeAlD
Suprofen—CYP2C9—hematopoietic system—hematologic cancer	0.000386	0.0496	CbGeAlD
Suprofen—Haemoglobin—Anagrelide—hematologic cancer	0.000362	0.00502	CcSEcCtD
Suprofen—Haemorrhage—Clofarabine—hematologic cancer	0.000362	0.00501	CcSEcCtD
Suprofen—Haemorrhage—Pentostatin—hematologic cancer	0.000361	0.00499	CcSEcCtD
Suprofen—Haemorrhage—Anagrelide—hematologic cancer	0.000361	0.00499	CcSEcCtD
Suprofen—Stinging—Prednisolone—hematologic cancer	0.000357	0.00494	CcSEcCtD
Suprofen—Photophobia—Alitretinoin—hematologic cancer	0.000352	0.00488	CcSEcCtD
Suprofen—PTGS1—hematopoietic system—hematologic cancer	0.000352	0.0453	CbGeAlD
Suprofen—Haemoglobin—Idarubicin—hematologic cancer	0.000349	0.00484	CcSEcCtD
Suprofen—Haemorrhage—Idarubicin—hematologic cancer	0.000348	0.00481	CcSEcCtD
Suprofen—Haemoglobin—Teniposide—hematologic cancer	0.00034	0.00471	CcSEcCtD
Suprofen—Haemorrhage—Teniposide—hematologic cancer	0.000338	0.00468	CcSEcCtD
Suprofen—PTGS2—hematopoietic system—hematologic cancer	0.000337	0.0433	CbGeAlD
Suprofen—Erythema—Methoxsalen—hematologic cancer	0.000329	0.00456	CcSEcCtD
Suprofen—Stinging—Triamcinolone—hematologic cancer	0.000328	0.00454	CcSEcCtD
Suprofen—Pruritus—Ruxolitinib—hematologic cancer	0.000318	0.0044	CcSEcCtD
Suprofen—Erythema—Daunorubicin—hematologic cancer	0.000315	0.00437	CcSEcCtD
Suprofen—Erythema—Clofarabine—hematologic cancer	0.000315	0.00437	CcSEcCtD
Suprofen—Haemoglobin—Busulfan—hematologic cancer	0.000315	0.00436	CcSEcCtD
Suprofen—Haemorrhage—Busulfan—hematologic cancer	0.000313	0.00434	CcSEcCtD
Suprofen—Haemoglobin—Procarbazine—hematologic cancer	0.000306	0.00423	CcSEcCtD
Suprofen—Haemorrhage—Procarbazine—hematologic cancer	0.000304	0.00421	CcSEcCtD
Suprofen—Haemoglobin—Bexarotene—hematologic cancer	0.0003	0.00415	CcSEcCtD
Suprofen—Haemoglobin—Dasatinib—hematologic cancer	0.0003	0.00415	CcSEcCtD
Suprofen—Haemoglobin—Fludarabine—hematologic cancer	0.000299	0.00414	CcSEcCtD
Suprofen—Haemorrhage—Dasatinib—hematologic cancer	0.000298	0.00413	CcSEcCtD
Suprofen—Haemorrhage—Bexarotene—hematologic cancer	0.000298	0.00413	CcSEcCtD
Suprofen—Stinging—Betamethasone—hematologic cancer	0.000298	0.00412	CcSEcCtD
Suprofen—Stinging—Dexamethasone—hematologic cancer	0.000298	0.00412	CcSEcCtD
Suprofen—Haemorrhage—Fludarabine—hematologic cancer	0.000297	0.00412	CcSEcCtD
Suprofen—Naproxen—UGT1A1—hematologic cancer	0.000286	0.191	CrCbGaD
Suprofen—PTGS2—Fluocinonide—Betamethasone—hematologic cancer	0.000283	0.209	CbGdCrCtD
Suprofen—PTGS2—Fluocinonide—Dexamethasone—hematologic cancer	0.000283	0.209	CbGdCrCtD
Suprofen—Tolmetin—MPO—hematologic cancer	0.000279	0.186	CrCbGaD
Suprofen—Discomfort—Methoxsalen—hematologic cancer	0.000277	0.00383	CcSEcCtD
Suprofen—Haemoglobin—Nilotinib—hematologic cancer	0.000277	0.00383	CcSEcCtD
Suprofen—PTGS2—Fluocinonide—Triamcinolone—hematologic cancer	0.000276	0.205	CbGdCrCtD
Suprofen—Haemorrhage—Nilotinib—hematologic cancer	0.000275	0.00381	CcSEcCtD
Suprofen—Haemoglobin—Imatinib—hematologic cancer	0.000275	0.00381	CcSEcCtD
Suprofen—Haemorrhage—Imatinib—hematologic cancer	0.000274	0.00379	CcSEcCtD
Suprofen—Erythema—Busulfan—hematologic cancer	0.000273	0.00378	CcSEcCtD
Suprofen—Haemoglobin—Cladribine—hematologic cancer	0.00027	0.00374	CcSEcCtD
Suprofen—Haemorrhage—Cladribine—hematologic cancer	0.000269	0.00373	CcSEcCtD
Suprofen—Pruritus—Vorinostat—hematologic cancer	0.000268	0.00372	CcSEcCtD
Suprofen—Discomfort—Daunorubicin—hematologic cancer	0.000265	0.00367	CcSEcCtD
Suprofen—Discomfort—Anagrelide—hematologic cancer	0.000264	0.00366	CcSEcCtD
Suprofen—Erythema—Bexarotene—hematologic cancer	0.000259	0.00359	CcSEcCtD
Suprofen—Erythema—Dasatinib—hematologic cancer	0.000259	0.00359	CcSEcCtD
Suprofen—Haemoglobin—Vinblastine—hematologic cancer	0.000259	0.00359	CcSEcCtD
Suprofen—Haemorrhage—Vinblastine—hematologic cancer	0.000258	0.00357	CcSEcCtD
Suprofen—CYP2C9—blood—hematologic cancer	0.000256	0.0329	CbGeAlD
Suprofen—Haemoglobin—Melphalan—hematologic cancer	0.000247	0.00342	CcSEcCtD
Suprofen—Haemorrhage—Melphalan—hematologic cancer	0.000245	0.0034	CcSEcCtD
Suprofen—Redness—Epirubicin—hematologic cancer	0.000243	0.00337	CcSEcCtD
Suprofen—Hypersensitivity—Mechlorethamine—hematologic cancer	0.00024	0.00333	CcSEcCtD
Suprofen—Haemoglobin—Lenalidomide—hematologic cancer	0.00024	0.00332	CcSEcCtD
Suprofen—Erythema—Nilotinib—hematologic cancer	0.00024	0.00332	CcSEcCtD
Suprofen—Haemorrhage—Lenalidomide—hematologic cancer	0.000239	0.0033	CcSEcCtD
Suprofen—Erythema—Imatinib—hematologic cancer	0.000238	0.0033	CcSEcCtD
Suprofen—Haemoglobin—Hydroxyurea—hematologic cancer	0.000237	0.00328	CcSEcCtD
Suprofen—Haemorrhage—Hydroxyurea—hematologic cancer	0.000235	0.00326	CcSEcCtD
Suprofen—Pain—Nelarabine—hematologic cancer	0.000235	0.00326	CcSEcCtD
Suprofen—Erythema—Cladribine—hematologic cancer	0.000234	0.00324	CcSEcCtD
Suprofen—PTGS1—blood—hematologic cancer	0.000233	0.03	CbGeAlD
Suprofen—Pruritus—Mechlorethamine—hematologic cancer	0.000231	0.00319	CcSEcCtD
Suprofen—Redness—Doxorubicin—hematologic cancer	0.000225	0.00312	CcSEcCtD
Suprofen—PTGS2—blood—hematologic cancer	0.000223	0.0287	CbGeAlD
Suprofen—Haemoglobin—Bortezomib—hematologic cancer	0.000221	0.00306	CcSEcCtD
Suprofen—Pain—Clofarabine—hematologic cancer	0.00022	0.00305	CcSEcCtD
Suprofen—Pain—Daunorubicin—hematologic cancer	0.00022	0.00305	CcSEcCtD
Suprofen—Haemorrhage—Bortezomib—hematologic cancer	0.00022	0.00304	CcSEcCtD
Suprofen—Haemoglobin—Bleomycin—hematologic cancer	0.000219	0.00303	CcSEcCtD
Suprofen—Pain—Anagrelide—hematologic cancer	0.000219	0.00303	CcSEcCtD
Suprofen—Pain—Pentostatin—hematologic cancer	0.000219	0.00303	CcSEcCtD
Suprofen—Discomfort—Dasatinib—hematologic cancer	0.000218	0.00302	CcSEcCtD
Suprofen—Discomfort—Bexarotene—hematologic cancer	0.000218	0.00302	CcSEcCtD
Suprofen—Haemorrhage—Bleomycin—hematologic cancer	0.000218	0.00302	CcSEcCtD
Suprofen—Discomfort—Fludarabine—hematologic cancer	0.000218	0.00301	CcSEcCtD
Suprofen—PTGS2—bone marrow—hematologic cancer	0.000216	0.0278	CbGeAlD
Suprofen—Ibuprofen—BCL2—hematologic cancer	0.000214	0.143	CrCbGaD
Suprofen—Erythema—Lenalidomide—hematologic cancer	0.000208	0.00288	CcSEcCtD
Suprofen—Haemoglobin—Thiotepa—hematologic cancer	0.000206	0.00285	CcSEcCtD
Suprofen—Erythema—Hydroxyurea—hematologic cancer	0.000205	0.00284	CcSEcCtD
Suprofen—Haemorrhage—Thiotepa—hematologic cancer	0.000205	0.00284	CcSEcCtD
Suprofen—Flurbiprofen—UGT1A1—hematologic cancer	0.000205	0.137	CrCbGaD
Suprofen—PTGS1—lung—hematologic cancer	0.000205	0.0263	CbGeAlD
Suprofen—Stinging—Epirubicin—hematologic cancer	0.000203	0.00281	CcSEcCtD
Suprofen—Discomfort—Nilotinib—hematologic cancer	0.000202	0.00279	CcSEcCtD
Suprofen—Discomfort—Imatinib—hematologic cancer	0.000201	0.00278	CcSEcCtD
Suprofen—Hypersensitivity—Methoxsalen—hematologic cancer	0.000198	0.00274	CcSEcCtD
Suprofen—Discomfort—Cladribine—hematologic cancer	0.000197	0.00273	CcSEcCtD
Suprofen—PTGS2—lung—hematologic cancer	0.000196	0.0251	CbGeAlD
Suprofen—PTGS1—testis—hematologic cancer	0.000193	0.0248	CbGeAlD
Suprofen—Hypersensitivity—Mercaptopurine—hematologic cancer	0.000192	0.00266	CcSEcCtD
Suprofen—Haemoglobin—Carmustine—hematologic cancer	0.000191	0.00265	CcSEcCtD
Suprofen—Erythema—Bortezomib—hematologic cancer	0.000191	0.00265	CcSEcCtD
Suprofen—Pain—Busulfan—hematologic cancer	0.00019	0.00264	CcSEcCtD
Suprofen—Haemorrhage—Carmustine—hematologic cancer	0.00019	0.00263	CcSEcCtD
Suprofen—Pruritus—Methoxsalen—hematologic cancer	0.00019	0.00263	CcSEcCtD
Suprofen—Erythema—Bleomycin—hematologic cancer	0.00019	0.00263	CcSEcCtD
Suprofen—Hypersensitivity—Clofarabine—hematologic cancer	0.00019	0.00262	CcSEcCtD
Suprofen—Hypersensitivity—Daunorubicin—hematologic cancer	0.00019	0.00262	CcSEcCtD
Suprofen—Haemoglobin—Alitretinoin—hematologic cancer	0.000189	0.00262	CcSEcCtD
Suprofen—Discomfort—Vinblastine—hematologic cancer	0.000189	0.00262	CcSEcCtD
Suprofen—Hypersensitivity—Pentostatin—hematologic cancer	0.000189	0.00261	CcSEcCtD
Suprofen—Haemorrhage—Alitretinoin—hematologic cancer	0.000188	0.00261	CcSEcCtD
Suprofen—Stinging—Doxorubicin—hematologic cancer	0.000188	0.0026	CcSEcCtD
Suprofen—Haemoglobin—Ifosfamide—hematologic cancer	0.000187	0.00259	CcSEcCtD
Suprofen—Erythema—Vinorelbine—hematologic cancer	0.000187	0.00258	CcSEcCtD
Suprofen—Haemorrhage—Ifosfamide—hematologic cancer	0.000186	0.00258	CcSEcCtD
Suprofen—Pain—Procarbazine—hematologic cancer	0.000185	0.00256	CcSEcCtD
Suprofen—Ibuprofen—UGT1A1—hematologic cancer	0.000182	0.122	CrCbGaD
Suprofen—Pruritus—Clofarabine—hematologic cancer	0.000182	0.00252	CcSEcCtD
Suprofen—Pruritus—Daunorubicin—hematologic cancer	0.000182	0.00252	CcSEcCtD
Suprofen—Hypersensitivity—Idarubicin—hematologic cancer	0.000182	0.00252	CcSEcCtD
Suprofen—Pruritus—Pentostatin—hematologic cancer	0.000181	0.00251	CcSEcCtD
Suprofen—Pruritus—Anagrelide—hematologic cancer	0.000181	0.00251	CcSEcCtD
Suprofen—Pain—Bexarotene—hematologic cancer	0.000181	0.00251	CcSEcCtD
Suprofen—Pain—Dasatinib—hematologic cancer	0.000181	0.00251	CcSEcCtD
Suprofen—Pain—Fludarabine—hematologic cancer	0.000181	0.0025	CcSEcCtD
Suprofen—Erythema—Thiotepa—hematologic cancer	0.000178	0.00247	CcSEcCtD
Suprofen—Haemoglobin—Irinotecan—hematologic cancer	0.000178	0.00246	CcSEcCtD
Suprofen—Haemoglobin—Mitoxantrone—hematologic cancer	0.000178	0.00246	CcSEcCtD
Suprofen—Hypersensitivity—Teniposide—hematologic cancer	0.000177	0.00245	CcSEcCtD
Suprofen—Haemorrhage—Irinotecan—hematologic cancer	0.000177	0.00245	CcSEcCtD
Suprofen—Haemorrhage—Mitoxantrone—hematologic cancer	0.000177	0.00245	CcSEcCtD
Suprofen—Discomfort—Lenalidomide—hematologic cancer	0.000175	0.00242	CcSEcCtD
Suprofen—Haemoglobin—Gemcitabine—hematologic cancer	0.000173	0.0024	CcSEcCtD
Suprofen—Discomfort—Hydroxyurea—hematologic cancer	0.000172	0.00239	CcSEcCtD
Suprofen—Haemorrhage—Gemcitabine—hematologic cancer	0.000172	0.00239	CcSEcCtD
Suprofen—Pain—Chlorambucil—hematologic cancer	0.000171	0.00237	CcSEcCtD
Suprofen—PTGS2—Fluticasone Propionate—Dexamethasone—hematologic cancer	0.000171	0.126	CbGdCrCtD
Suprofen—PTGS2—Fluticasone Propionate—Betamethasone—hematologic cancer	0.000171	0.126	CbGdCrCtD
Suprofen—Pruritus—Teniposide—hematologic cancer	0.00017	0.00235	CcSEcCtD
Suprofen—Pain—Nilotinib—hematologic cancer	0.000167	0.00232	CcSEcCtD
Suprofen—PTGS2—Fluticasone Propionate—Triamcinolone—hematologic cancer	0.000167	0.124	CbGdCrCtD
Suprofen—Pain—Imatinib—hematologic cancer	0.000166	0.0023	CcSEcCtD
Suprofen—Erythema—Carmustine—hematologic cancer	0.000166	0.00229	CcSEcCtD
Suprofen—Hypersensitivity—Busulfan—hematologic cancer	0.000164	0.00227	CcSEcCtD
Suprofen—Erythema—Alitretinoin—hematologic cancer	0.000164	0.00227	CcSEcCtD
Suprofen—Pain—Cladribine—hematologic cancer	0.000163	0.00226	CcSEcCtD
Suprofen—Erythema—Ifosfamide—hematologic cancer	0.000162	0.00225	CcSEcCtD
Suprofen—Discomfort—Bortezomib—hematologic cancer	0.000161	0.00223	CcSEcCtD
Suprofen—Discomfort—Bleomycin—hematologic cancer	0.00016	0.00221	CcSEcCtD
Suprofen—Hypersensitivity—Procarbazine—hematologic cancer	0.000159	0.0022	CcSEcCtD
Suprofen—Pruritus—Busulfan—hematologic cancer	0.000158	0.00218	CcSEcCtD
Suprofen—Discomfort—Vinorelbine—hematologic cancer	0.000157	0.00217	CcSEcCtD
Suprofen—Pain—Vinblastine—hematologic cancer	0.000157	0.00217	CcSEcCtD
Suprofen—Hypersensitivity—Bexarotene—hematologic cancer	0.000156	0.00216	CcSEcCtD
Suprofen—Hypersensitivity—Dasatinib—hematologic cancer	0.000156	0.00216	CcSEcCtD
Suprofen—Hypersensitivity—Fludarabine—hematologic cancer	0.000156	0.00215	CcSEcCtD
Suprofen—Erythema—Mitoxantrone—hematologic cancer	0.000154	0.00213	CcSEcCtD
Suprofen—Pruritus—Procarbazine—hematologic cancer	0.000153	0.00212	CcSEcCtD
Suprofen—Erythema—Gemcitabine—hematologic cancer	0.00015	0.00208	CcSEcCtD
Suprofen—Pruritus—Dasatinib—hematologic cancer	0.00015	0.00207	CcSEcCtD
Suprofen—Pruritus—Bexarotene—hematologic cancer	0.00015	0.00207	CcSEcCtD
Suprofen—Pruritus—Fludarabine—hematologic cancer	0.000149	0.00207	CcSEcCtD
Suprofen—Pain—Melphalan—hematologic cancer	0.000149	0.00206	CcSEcCtD
Suprofen—Hypersensitivity—Chlorambucil—hematologic cancer	0.000147	0.00204	CcSEcCtD
Suprofen—Haemoglobin—Prednisolone—hematologic cancer	0.000146	0.00202	CcSEcCtD
Suprofen—Haemorrhage—Prednisolone—hematologic cancer	0.000145	0.00201	CcSEcCtD
Suprofen—Discomfort—Thalidomide—hematologic cancer	0.000145	0.00201	CcSEcCtD
Suprofen—Pain—Lenalidomide—hematologic cancer	0.000145	0.00201	CcSEcCtD
Suprofen—Hypersensitivity—Nilotinib—hematologic cancer	0.000144	0.002	CcSEcCtD
Suprofen—Hypersensitivity—Imatinib—hematologic cancer	0.000143	0.00198	CcSEcCtD
Suprofen—Pain—Hydroxyurea—hematologic cancer	0.000143	0.00198	CcSEcCtD
Suprofen—Pruritus—Chlorambucil—hematologic cancer	0.000142	0.00196	CcSEcCtD
Suprofen—Hypersensitivity—Cladribine—hematologic cancer	0.000141	0.00195	CcSEcCtD
Suprofen—PTGS1—lymph node—hematologic cancer	0.00014	0.018	CbGeAlD
Suprofen—Erythema—Cisplatin—hematologic cancer	0.00014	0.00194	CcSEcCtD
Suprofen—Pruritus—Nilotinib—hematologic cancer	0.000138	0.00192	CcSEcCtD
Suprofen—Discomfort—Alitretinoin—hematologic cancer	0.000138	0.00191	CcSEcCtD
Suprofen—Pruritus—Imatinib—hematologic cancer	0.000138	0.00191	CcSEcCtD
Suprofen—Discomfort—Ifosfamide—hematologic cancer	0.000136	0.00189	CcSEcCtD
Suprofen—Pruritus—Cladribine—hematologic cancer	0.000135	0.00187	CcSEcCtD
Suprofen—Hypersensitivity—Vinblastine—hematologic cancer	0.000135	0.00187	CcSEcCtD
Suprofen—Haemoglobin—Triamcinolone—hematologic cancer	0.000134	0.00186	CcSEcCtD
Suprofen—PTGS2—lymph node—hematologic cancer	0.000134	0.0172	CbGeAlD
Suprofen—Haemorrhage—Triamcinolone—hematologic cancer	0.000133	0.00185	CcSEcCtD
Suprofen—Pain—Bortezomib—hematologic cancer	0.000133	0.00185	CcSEcCtD
Suprofen—Pain—Bleomycin—hematologic cancer	0.000132	0.00183	CcSEcCtD
Suprofen—Pain—Vinorelbine—hematologic cancer	0.00013	0.0018	CcSEcCtD
Suprofen—Discomfort—Mitoxantrone—hematologic cancer	0.00013	0.00179	CcSEcCtD
Suprofen—Discomfort—Irinotecan—hematologic cancer	0.00013	0.00179	CcSEcCtD
Suprofen—Hypersensitivity—Melphalan—hematologic cancer	0.000128	0.00178	CcSEcCtD
Suprofen—Erythema—Prednisolone—hematologic cancer	0.000126	0.00175	CcSEcCtD
Suprofen—Discomfort—Gemcitabine—hematologic cancer	0.000126	0.00175	CcSEcCtD
Suprofen—Hypersensitivity—Lenalidomide—hematologic cancer	0.000125	0.00173	CcSEcCtD
Suprofen—Pain—Thiotepa—hematologic cancer	0.000124	0.00172	CcSEcCtD
Suprofen—Pruritus—Melphalan—hematologic cancer	0.000123	0.00171	CcSEcCtD
Suprofen—Hypersensitivity—Hydroxyurea—hematologic cancer	0.000123	0.00171	CcSEcCtD
Suprofen—Haemoglobin—Betamethasone—hematologic cancer	0.000122	0.00168	CcSEcCtD
Suprofen—Haemoglobin—Dexamethasone—hematologic cancer	0.000122	0.00168	CcSEcCtD
Suprofen—Haemorrhage—Dexamethasone—hematologic cancer	0.000121	0.00168	CcSEcCtD
Suprofen—Haemorrhage—Betamethasone—hematologic cancer	0.000121	0.00168	CcSEcCtD
Suprofen—Pain—Thalidomide—hematologic cancer	0.00012	0.00167	CcSEcCtD
Suprofen—Pruritus—Lenalidomide—hematologic cancer	0.00012	0.00166	CcSEcCtD
Suprofen—Discomfort—Cisplatin—hematologic cancer	0.000118	0.00163	CcSEcCtD
Suprofen—Erythema—Triamcinolone—hematologic cancer	0.000116	0.00161	CcSEcCtD
Suprofen—Pain—Carmustine—hematologic cancer	0.000116	0.0016	CcSEcCtD
Suprofen—Hypersensitivity—Bortezomib—hematologic cancer	0.000115	0.00159	CcSEcCtD
Suprofen—Pain—Alitretinoin—hematologic cancer	0.000115	0.00159	CcSEcCtD
Suprofen—Hypersensitivity—Bleomycin—hematologic cancer	0.000114	0.00158	CcSEcCtD
Suprofen—Pain—Ifosfamide—hematologic cancer	0.000113	0.00157	CcSEcCtD
Suprofen—Hypersensitivity—Vinorelbine—hematologic cancer	0.000112	0.00155	CcSEcCtD
Suprofen—Pruritus—Bortezomib—hematologic cancer	0.00011	0.00153	CcSEcCtD
Suprofen—Pain—Vincristine—hematologic cancer	0.00011	0.00153	CcSEcCtD
Suprofen—Pruritus—Bleomycin—hematologic cancer	0.00011	0.00152	CcSEcCtD
Suprofen—Pruritus—Vinorelbine—hematologic cancer	0.000108	0.00149	CcSEcCtD
Suprofen—Discomfort—Etoposide—hematologic cancer	0.000108	0.00149	CcSEcCtD
Suprofen—Pain—Mitoxantrone—hematologic cancer	0.000107	0.00149	CcSEcCtD
Suprofen—Pain—Irinotecan—hematologic cancer	0.000107	0.00149	CcSEcCtD
Suprofen—Hypersensitivity—Thiotepa—hematologic cancer	0.000107	0.00148	CcSEcCtD
Suprofen—Discomfort—Prednisolone—hematologic cancer	0.000106	0.00147	CcSEcCtD
Suprofen—Haemoglobin—Prednisone—hematologic cancer	0.000106	0.00147	CcSEcCtD
Suprofen—Haemorrhage—Prednisone—hematologic cancer	0.000105	0.00146	CcSEcCtD
Suprofen—Erythema—Betamethasone—hematologic cancer	0.000105	0.00146	CcSEcCtD
Suprofen—Erythema—Dexamethasone—hematologic cancer	0.000105	0.00146	CcSEcCtD
Suprofen—Pain—Gemcitabine—hematologic cancer	0.000105	0.00145	CcSEcCtD
Suprofen—Hypersensitivity—Thalidomide—hematologic cancer	0.000104	0.00144	CcSEcCtD
Suprofen—Pruritus—Thiotepa—hematologic cancer	0.000103	0.00143	CcSEcCtD
Suprofen—Hypersensitivity—Carmustine—hematologic cancer	9.96e-05	0.00138	CcSEcCtD
Suprofen—Pruritus—Thalidomide—hematologic cancer	9.96e-05	0.00138	CcSEcCtD
Suprofen—Hypersensitivity—Alitretinoin—hematologic cancer	9.87e-05	0.00137	CcSEcCtD
Suprofen—Discomfort—Triamcinolone—hematologic cancer	9.77e-05	0.00135	CcSEcCtD
Suprofen—Pain—Cisplatin—hematologic cancer	9.76e-05	0.00135	CcSEcCtD
Suprofen—Hypersensitivity—Ifosfamide—hematologic cancer	9.75e-05	0.00135	CcSEcCtD
Suprofen—Hypersensitivity—Vincristine—hematologic cancer	9.51e-05	0.00132	CcSEcCtD
Suprofen—Pruritus—Alitretinoin—hematologic cancer	9.47e-05	0.00131	CcSEcCtD
Suprofen—Pruritus—Ifosfamide—hematologic cancer	9.36e-05	0.0013	CcSEcCtD
Suprofen—Hypersensitivity—Irinotecan—hematologic cancer	9.26e-05	0.00128	CcSEcCtD
Suprofen—Hypersensitivity—Mitoxantrone—hematologic cancer	9.26e-05	0.00128	CcSEcCtD
Suprofen—Erythema—Prednisone—hematologic cancer	9.18e-05	0.00127	CcSEcCtD
Suprofen—Pain—Etoposide—hematologic cancer	8.94e-05	0.00124	CcSEcCtD
Suprofen—Discomfort—Dexamethasone—hematologic cancer	8.87e-05	0.00123	CcSEcCtD
Suprofen—Discomfort—Betamethasone—hematologic cancer	8.87e-05	0.00123	CcSEcCtD
Suprofen—Haemoglobin—Methotrexate—hematologic cancer	8.86e-05	0.00123	CcSEcCtD
Suprofen—Pain—Prednisolone—hematologic cancer	8.82e-05	0.00122	CcSEcCtD
Suprofen—Haemorrhage—Methotrexate—hematologic cancer	8.81e-05	0.00122	CcSEcCtD
Suprofen—Pruritus—Gemcitabine—hematologic cancer	8.66e-05	0.0012	CcSEcCtD
Suprofen—Hypersensitivity—Cisplatin—hematologic cancer	8.41e-05	0.00116	CcSEcCtD
Suprofen—Haemoglobin—Epirubicin—hematologic cancer	8.29e-05	0.00115	CcSEcCtD
Suprofen—Haemorrhage—Epirubicin—hematologic cancer	8.25e-05	0.00114	CcSEcCtD
Suprofen—Pain—Triamcinolone—hematologic cancer	8.11e-05	0.00112	CcSEcCtD
Suprofen—Discomfort—Prednisone—hematologic cancer	7.72e-05	0.00107	CcSEcCtD
Suprofen—Hypersensitivity—Etoposide—hematologic cancer	7.7e-05	0.00107	CcSEcCtD
Suprofen—Fenoprofen—ALB—hematologic cancer	7.69e-05	0.0514	CrCbGaD
Suprofen—Erythema—Methotrexate—hematologic cancer	7.67e-05	0.00106	CcSEcCtD
Suprofen—Haemoglobin—Doxorubicin—hematologic cancer	7.67e-05	0.00106	CcSEcCtD
Suprofen—Haemorrhage—Doxorubicin—hematologic cancer	7.63e-05	0.00106	CcSEcCtD
Suprofen—Hypersensitivity—Prednisolone—hematologic cancer	7.6e-05	0.00105	CcSEcCtD
Suprofen—Pruritus—Etoposide—hematologic cancer	7.39e-05	0.00102	CcSEcCtD
Suprofen—Pain—Dexamethasone—hematologic cancer	7.36e-05	0.00102	CcSEcCtD
Suprofen—Pain—Betamethasone—hematologic cancer	7.36e-05	0.00102	CcSEcCtD
Suprofen—Erythema—Epirubicin—hematologic cancer	7.18e-05	0.000994	CcSEcCtD
Suprofen—Naproxen—ALB—hematologic cancer	7e-05	0.0468	CrCbGaD
Suprofen—Hypersensitivity—Triamcinolone—hematologic cancer	6.98e-05	0.000967	CcSEcCtD
Suprofen—Pruritus—Triamcinolone—hematologic cancer	6.71e-05	0.000929	CcSEcCtD
Suprofen—Erythema—Doxorubicin—hematologic cancer	6.64e-05	0.00092	CcSEcCtD
Suprofen—Discomfort—Methotrexate—hematologic cancer	6.45e-05	0.000893	CcSEcCtD
Suprofen—Pruritus—Dexamethasone—hematologic cancer	6.09e-05	0.000843	CcSEcCtD
Suprofen—Pruritus—Betamethasone—hematologic cancer	6.09e-05	0.000843	CcSEcCtD
Suprofen—Discomfort—Epirubicin—hematologic cancer	6.04e-05	0.000836	CcSEcCtD
Suprofen—Discomfort—Doxorubicin—hematologic cancer	5.59e-05	0.000774	CcSEcCtD
Suprofen—Hypersensitivity—Prednisone—hematologic cancer	5.52e-05	0.000764	CcSEcCtD
Suprofen—Pain—Methotrexate—hematologic cancer	5.35e-05	0.000741	CcSEcCtD
Suprofen—Pruritus—Prednisone—hematologic cancer	5.3e-05	0.000734	CcSEcCtD
Suprofen—Flurbiprofen—ALB—hematologic cancer	5.02e-05	0.0336	CrCbGaD
Suprofen—Pain—Epirubicin—hematologic cancer	5.01e-05	0.000694	CcSEcCtD
Suprofen—Pain—Doxorubicin—hematologic cancer	4.64e-05	0.000642	CcSEcCtD
Suprofen—Hypersensitivity—Methotrexate—hematologic cancer	4.61e-05	0.000639	CcSEcCtD
Suprofen—Ketoprofen—ALB—hematologic cancer	4.54e-05	0.0304	CrCbGaD
Suprofen—Ibuprofen—ALB—hematologic cancer	4.47e-05	0.0299	CrCbGaD
Suprofen—Pruritus—Methotrexate—hematologic cancer	4.43e-05	0.000613	CcSEcCtD
Suprofen—Hypersensitivity—Epirubicin—hematologic cancer	4.32e-05	0.000598	CcSEcCtD
Suprofen—Ibuprofen—ABCB1—hematologic cancer	4.26e-05	0.0285	CrCbGaD
Suprofen—Pruritus—Epirubicin—hematologic cancer	4.15e-05	0.000574	CcSEcCtD
Suprofen—Hypersensitivity—Doxorubicin—hematologic cancer	3.99e-05	0.000553	CcSEcCtD
Suprofen—Pruritus—Doxorubicin—hematologic cancer	3.84e-05	0.000531	CcSEcCtD
Suprofen—PTGS2—Disease—NUP98—hematologic cancer	8.27e-06	0.00021	CbGpPWpGaD
Suprofen—PTGS2—Disease—STAT5B—hematologic cancer	8.27e-06	0.00021	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—GBA—hematologic cancer	8.25e-06	0.000209	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—SLC35B2—hematologic cancer	8.25e-06	0.000209	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—MTR—hematologic cancer	8.24e-06	0.000209	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—ABCG2—hematologic cancer	8.24e-06	0.000209	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—GSTP1—hematologic cancer	8.2e-06	0.000208	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—IDH1—hematologic cancer	8.12e-06	0.000206	CbGpPWpGaD
Suprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	8.11e-06	0.000206	CbGpPWpGaD
Suprofen—PTGS2—Disease—CST3—hematologic cancer	8.09e-06	0.000205	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—ENO2—hematologic cancer	8.08e-06	0.000205	CbGpPWpGaD
Suprofen—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	8.05e-06	0.000204	CbGpPWpGaD
Suprofen—PTGS2—Disease—ADCY7—hematologic cancer	8.03e-06	0.000204	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—ABCC3—hematologic cancer	8.03e-06	0.000204	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—GSTO1—hematologic cancer	8.03e-06	0.000204	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—TXN—hematologic cancer	8.03e-06	0.000204	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—CD44—hematologic cancer	7.99e-06	0.000203	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—NQO1—hematologic cancer	7.99e-06	0.000203	CbGpPWpGaD
Suprofen—PTGS2—Disease—NUP214—hematologic cancer	7.97e-06	0.000202	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—SPHK1—hematologic cancer	7.85e-06	0.000199	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—GSTT1—hematologic cancer	7.84e-06	0.000199	CbGpPWpGaD
Suprofen—PTGS2—Disease—MTR—hematologic cancer	7.81e-06	0.000198	CbGpPWpGaD
Suprofen—PTGS2—Disease—XIAP—hematologic cancer	7.81e-06	0.000198	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—ABCB1—hematologic cancer	7.76e-06	0.000197	CbGpPWpGaD
Suprofen—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	7.72e-06	0.000196	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—SDC1—hematologic cancer	7.66e-06	0.000194	CbGpPWpGaD
Suprofen—PTGS2—Disease—ENO2—hematologic cancer	7.66e-06	0.000194	CbGpPWpGaD
Suprofen—PTGS2—Disease—SMARCA4—hematologic cancer	7.61e-06	0.000193	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—CYCS—hematologic cancer	7.56e-06	0.000192	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—UGT1A1—hematologic cancer	7.55e-06	0.000191	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—MTAP—hematologic cancer	7.54e-06	0.000191	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—NCOR1—hematologic cancer	7.54e-06	0.000191	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—GSTM1—hematologic cancer	7.54e-06	0.000191	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—HSP90AA1—hematologic cancer	7.51e-06	0.000191	CbGpPWpGaD
Suprofen—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	7.39e-06	0.000188	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—CRABP1—hematologic cancer	7.34e-06	0.000186	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—SLC22A1—hematologic cancer	7.34e-06	0.000186	CbGpPWpGaD
Suprofen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	7.32e-06	0.000186	CbGpPWpGaD
Suprofen—PTGS2—Disease—SDC1—hematologic cancer	7.26e-06	0.000184	CbGpPWpGaD
Suprofen—PTGS1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	7.22e-06	0.000183	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—ALOX5—hematologic cancer	7.15e-06	0.000181	CbGpPWpGaD
Suprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	7.15e-06	0.000181	CbGpPWpGaD
Suprofen—PTGS2—Disease—LCK—hematologic cancer	7.03e-06	0.000178	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—NUP98—hematologic cancer	6.93e-06	0.000176	CbGpPWpGaD
Suprofen—PTGS1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	6.91e-06	0.000175	CbGpPWpGaD
Suprofen—PTGS2—Disease—H3F3A—hematologic cancer	6.89e-06	0.000175	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—NCOA3—hematologic cancer	6.73e-06	0.000171	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—ADCY7—hematologic cancer	6.73e-06	0.000171	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—FHL2—hematologic cancer	6.72e-06	0.000171	CbGpPWpGaD
Suprofen—PTGS2—Disease—PRKCZ—hematologic cancer	6.7e-06	0.00017	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—NUP214—hematologic cancer	6.68e-06	0.000169	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—GSTP1—hematologic cancer	6.67e-06	0.000169	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—MTHFR—hematologic cancer	6.66e-06	0.000169	CbGpPWpGaD
Suprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.61e-06	0.000168	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—AGRN—hematologic cancer	6.59e-06	0.000167	CbGpPWpGaD
Suprofen—PTGS2—Disease—CALR—hematologic cancer	6.58e-06	0.000167	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—MTR—hematologic cancer	6.54e-06	0.000166	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—ABCG2—hematologic cancer	6.54e-06	0.000166	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—NQO1—hematologic cancer	6.51e-06	0.000165	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—CD44—hematologic cancer	6.51e-06	0.000165	CbGpPWpGaD
Suprofen—PTGS2—Disease—PARP1—hematologic cancer	6.47e-06	0.000164	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—ENO2—hematologic cancer	6.42e-06	0.000163	CbGpPWpGaD
Suprofen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	6.38e-06	0.000162	CbGpPWpGaD
Suprofen—PTGS2—Disease—FBXW7—hematologic cancer	6.37e-06	0.000162	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—ABCB1—hematologic cancer	6.31e-06	0.00016	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—IDH2—hematologic cancer	6.25e-06	0.000159	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—HMMR—hematologic cancer	6.25e-06	0.000159	CbGpPWpGaD
Suprofen—PTGS2—Disease—HDAC2—hematologic cancer	6.25e-06	0.000158	CbGpPWpGaD
Suprofen—PTGS2—Disease—CXCR4—hematologic cancer	6.25e-06	0.000158	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—GSTT1—hematologic cancer	6.22e-06	0.000158	CbGpPWpGaD
Suprofen—PTGS2—Disease—CD44—hematologic cancer	6.18e-06	0.000157	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—CYCS—hematologic cancer	6.16e-06	0.000156	CbGpPWpGaD
Suprofen—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.13e-06	0.000155	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—GSTM1—hematologic cancer	6.13e-06	0.000155	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—NCOR1—hematologic cancer	6.13e-06	0.000155	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—HSP90AA1—hematologic cancer	6.13e-06	0.000155	CbGpPWpGaD
Suprofen—PTGS2—Disease—CBL—hematologic cancer	6.09e-06	0.000154	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—SDC1—hematologic cancer	6.08e-06	0.000154	CbGpPWpGaD
Suprofen—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	6.04e-06	0.000153	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	5.89e-06	0.00015	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—ARNTL—hematologic cancer	5.88e-06	0.000149	CbGpPWpGaD
Suprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.81e-06	0.000147	CbGpPWpGaD
Suprofen—PTGS2—Disease—HSP90AA1—hematologic cancer	5.81e-06	0.000147	CbGpPWpGaD
Suprofen—PTGS2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.74e-06	0.000145	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—ACP5—hematologic cancer	5.72e-06	0.000145	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—CA9—hematologic cancer	5.72e-06	0.000145	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—NCOR2—hematologic cancer	5.64e-06	0.000143	CbGpPWpGaD
Suprofen—PTGS2—Disease—STAT1—hematologic cancer	5.6e-06	0.000142	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—PIK3CG—hematologic cancer	5.6e-06	0.000142	CbGpPWpGaD
Suprofen—PTGS1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.51e-06	0.00014	CbGpPWpGaD
Suprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.49e-06	0.000139	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—GSTP1—hematologic cancer	5.43e-06	0.000138	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—MTHFR—hematologic cancer	5.41e-06	0.000137	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—IDH1—hematologic cancer	5.38e-06	0.000136	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—GSTO1—hematologic cancer	5.31e-06	0.000135	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—TXN—hematologic cancer	5.31e-06	0.000135	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—ABCC3—hematologic cancer	5.31e-06	0.000135	CbGpPWpGaD
Suprofen—PTGS1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.26e-06	0.000133	CbGpPWpGaD
Suprofen—PTGS2—Disease—GRB2—hematologic cancer	5.24e-06	0.000133	CbGpPWpGaD
Suprofen—PTGS2—Disease—PDGFA—hematologic cancer	5.23e-06	0.000133	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—SPHK1—hematologic cancer	5.2e-06	0.000132	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—CREBBP—hematologic cancer	5.19e-06	0.000132	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—CD44—hematologic cancer	5.17e-06	0.000131	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—NQO1—hematologic cancer	5.17e-06	0.000131	CbGpPWpGaD
Suprofen—PTGS2—Disease—KITLG—hematologic cancer	5.15e-06	0.000131	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—ABCB1—hematologic cancer	5.14e-06	0.00013	CbGpPWpGaD
Suprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.06e-06	0.000128	CbGpPWpGaD
Suprofen—PTGS2—Disease—STAT5A—hematologic cancer	5.03e-06	0.000128	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—UGT1A1—hematologic cancer	5e-06	0.000127	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—GSTM1—hematologic cancer	4.99e-06	0.000127	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—NCOR1—hematologic cancer	4.99e-06	0.000127	CbGpPWpGaD
Suprofen—PTGS2—Disease—CDKN2B—hematologic cancer	4.99e-06	0.000127	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—PIK3CD—hematologic cancer	4.92e-06	0.000125	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—CYCS—hematologic cancer	4.89e-06	0.000124	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—HSP90AA1—hematologic cancer	4.86e-06	0.000123	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—SLC22A1—hematologic cancer	4.86e-06	0.000123	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—CRABP1—hematologic cancer	4.86e-06	0.000123	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—ALB—hematologic cancer	4.86e-06	0.000123	CbGpPWpGaD
Suprofen—PTGS2—Disease—CD86—hematologic cancer	4.83e-06	0.000122	CbGpPWpGaD
Suprofen—PTGS2—Disease—HES1—hematologic cancer	4.76e-06	0.000121	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—ALOX5—hematologic cancer	4.74e-06	0.00012	CbGpPWpGaD
Suprofen—PTGS2—Disease—NCOR1—hematologic cancer	4.73e-06	0.00012	CbGpPWpGaD
Suprofen—PTGS2—Disease—FGF1—hematologic cancer	4.68e-06	0.000119	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—PIK3R1—hematologic cancer	4.65e-06	0.000118	CbGpPWpGaD
Suprofen—PTGS2—Disease—FOXO1—hematologic cancer	4.61e-06	0.000117	CbGpPWpGaD
Suprofen—PTGS2—Disease—PDGFRB—hematologic cancer	4.6e-06	0.000117	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—NUP98—hematologic cancer	4.59e-06	0.000116	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—PIK3CG—hematologic cancer	4.55e-06	0.000115	CbGpPWpGaD
Suprofen—PTGS2—Disease—PDGFRA—hematologic cancer	4.53e-06	0.000115	CbGpPWpGaD
Suprofen—PTGS2—Disease—JAK1—hematologic cancer	4.52e-06	0.000115	CbGpPWpGaD
Suprofen—PTGS2—Disease—PRKCG—hematologic cancer	4.52e-06	0.000115	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—ADCY7—hematologic cancer	4.45e-06	0.000113	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—NCOA3—hematologic cancer	4.45e-06	0.000113	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—NUP214—hematologic cancer	4.42e-06	0.000112	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—MTHFR—hematologic cancer	4.41e-06	0.000112	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.38e-06	0.000111	CbGpPWpGaD
Suprofen—PTGS2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.38e-06	0.000111	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—MTR—hematologic cancer	4.33e-06	0.00011	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—ABCG2—hematologic cancer	4.33e-06	0.00011	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—GSTP1—hematologic cancer	4.31e-06	0.000109	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—PIK3CB—hematologic cancer	4.29e-06	0.000109	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—ENO2—hematologic cancer	4.25e-06	0.000108	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—CREBBP—hematologic cancer	4.22e-06	0.000107	CbGpPWpGaD
Suprofen—PTGS2—Disease—MTHFR—hematologic cancer	4.18e-06	0.000106	CbGpPWpGaD
Suprofen—PTGS2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.17e-06	0.000106	CbGpPWpGaD
Suprofen—PTGS2—Disease—TERT—hematologic cancer	4.17e-06	0.000106	CbGpPWpGaD
Suprofen—PTGS2—Disease—HLA-A—hematologic cancer	4.17e-06	0.000106	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—GSTT1—hematologic cancer	4.12e-06	0.000105	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—ABCB1—hematologic cancer	4.08e-06	0.000104	CbGpPWpGaD
Suprofen—PTGS2—Disease—PDGFB—hematologic cancer	4.07e-06	0.000103	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.06e-06	0.000103	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—SDC1—hematologic cancer	4.03e-06	0.000102	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—PIK3CD—hematologic cancer	4e-06	0.000101	CbGpPWpGaD
Suprofen—PTGS2—Disease—TSC2—hematologic cancer	3.98e-06	0.000101	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—NCOR1—hematologic cancer	3.96e-06	0.000101	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—GSTM1—hematologic cancer	3.96e-06	0.000101	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—ALB—hematologic cancer	3.95e-06	0.0001	CbGpPWpGaD
Suprofen—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.89e-06	9.86e-05	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.85e-06	9.76e-05	CbGpPWpGaD
Suprofen—PTGS2—Disease—FGFR3—hematologic cancer	3.83e-06	9.71e-05	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.8e-06	9.63e-05	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—PIK3R1—hematologic cancer	3.78e-06	9.58e-05	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—PIK3CG—hematologic cancer	3.71e-06	9.4e-05	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—PTEN—hematologic cancer	3.71e-06	9.4e-05	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.63e-06	9.22e-05	CbGpPWpGaD
Suprofen—PTGS2—Disease—BAD—hematologic cancer	3.63e-06	9.21e-05	CbGpPWpGaD
Suprofen—PTGS2—Disease—NOTCH1—hematologic cancer	3.59e-06	9.12e-05	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—EP300—hematologic cancer	3.53e-06	8.97e-05	CbGpPWpGaD
Suprofen—PTGS2—Disease—CD80—hematologic cancer	3.52e-06	8.93e-05	CbGpPWpGaD
Suprofen—PTGS2—Disease—KIT—hematologic cancer	3.51e-06	8.91e-05	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—MTHFR—hematologic cancer	3.5e-06	8.89e-05	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—PIK3CB—hematologic cancer	3.49e-06	8.84e-05	CbGpPWpGaD
Suprofen—PTGS2—Disease—PTPN11—hematologic cancer	3.45e-06	8.76e-05	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—CREBBP—hematologic cancer	3.44e-06	8.72e-05	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—CD44—hematologic cancer	3.42e-06	8.69e-05	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—NQO1—hematologic cancer	3.42e-06	8.69e-05	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.35e-06	8.51e-05	CbGpPWpGaD
Suprofen—PTGS2—Disease—CREB1—hematologic cancer	3.35e-06	8.49e-05	CbGpPWpGaD
Suprofen—PTGS2—Disease—BRAF—hematologic cancer	3.3e-06	8.38e-05	CbGpPWpGaD
Suprofen—PTGS2—Disease—IL6R—hematologic cancer	3.26e-06	8.28e-05	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—PIK3CD—hematologic cancer	3.26e-06	8.27e-05	CbGpPWpGaD
Suprofen—PTGS2—Disease—CREBBP—hematologic cancer	3.26e-06	8.27e-05	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—CYCS—hematologic cancer	3.24e-06	8.22e-05	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	3.22e-06	8.17e-05	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—ALB—hematologic cancer	3.22e-06	8.16e-05	CbGpPWpGaD
Suprofen—PTGS2—Disease—MAP2K1—hematologic cancer	3.11e-06	7.89e-05	CbGpPWpGaD
Suprofen—PTGS2—Disease—PIK3CD—hematologic cancer	3.09e-06	7.84e-05	CbGpPWpGaD
Suprofen—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.09e-06	7.83e-05	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—PIK3R1—hematologic cancer	3.08e-06	7.81e-05	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—PTEN—hematologic cancer	3.01e-06	7.64e-05	CbGpPWpGaD
Suprofen—PTGS2—Disease—FGF2—hematologic cancer	2.96e-06	7.5e-05	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—PIK3CG—hematologic cancer	2.94e-06	7.47e-05	CbGpPWpGaD
Suprofen—PTGS2—Disease—PIK3R1—hematologic cancer	2.92e-06	7.4e-05	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.9e-06	7.35e-05	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—EP300—hematologic cancer	2.87e-06	7.29e-05	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—GSTP1—hematologic cancer	2.86e-06	7.25e-05	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—PIK3CB—hematologic cancer	2.84e-06	7.21e-05	CbGpPWpGaD
Suprofen—PTGS2—Disease—JAK2—hematologic cancer	2.84e-06	7.19e-05	CbGpPWpGaD
Suprofen—PTGS2—Disease—MDM2—hematologic cancer	2.77e-06	7.02e-05	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.76e-06	7.01e-05	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—CREBBP—hematologic cancer	2.73e-06	6.92e-05	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—ABCB1—hematologic cancer	2.7e-06	6.86e-05	CbGpPWpGaD
Suprofen—PTGS2—Disease—PIK3CB—hematologic cancer	2.69e-06	6.83e-05	CbGpPWpGaD
Suprofen—PTGS2—Disease—MTOR—hematologic cancer	2.69e-06	6.83e-05	CbGpPWpGaD
Suprofen—PTGS2—Disease—CD4—hematologic cancer	2.69e-06	6.82e-05	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—NCOR1—hematologic cancer	2.62e-06	6.66e-05	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—GSTM1—hematologic cancer	2.62e-06	6.66e-05	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—PIK3CA—hematologic cancer	2.61e-06	6.63e-05	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—PIK3CD—hematologic cancer	2.59e-06	6.56e-05	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—ALB—hematologic cancer	2.55e-06	6.48e-05	CbGpPWpGaD
Suprofen—PTGS2—Disease—CDKN1B—hematologic cancer	2.53e-06	6.41e-05	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—PTEN—hematologic cancer	2.45e-06	6.23e-05	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—PIK3R1—hematologic cancer	2.44e-06	6.2e-05	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—EP300—hematologic cancer	2.34e-06	5.94e-05	CbGpPWpGaD
Suprofen—PTGS2—Disease—CDKN1A—hematologic cancer	2.33e-06	5.92e-05	CbGpPWpGaD
Suprofen—PTGS2—Disease—PTEN—hematologic cancer	2.33e-06	5.9e-05	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—MTHFR—hematologic cancer	2.32e-06	5.88e-05	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—PIK3CB—hematologic cancer	2.26e-06	5.72e-05	CbGpPWpGaD
Suprofen—PTGS2—Disease—EP300—hematologic cancer	2.22e-06	5.63e-05	CbGpPWpGaD
Suprofen—PTGS2—Disease—SRC—hematologic cancer	2.16e-06	5.47e-05	CbGpPWpGaD
Suprofen—UGT2B7—Metabolism—AKT1—hematologic cancer	2.14e-06	5.42e-05	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—PIK3CA—hematologic cancer	2.12e-06	5.39e-05	CbGpPWpGaD
Suprofen—PTGS2—Disease—STAT3—hematologic cancer	2.08e-06	5.28e-05	CbGpPWpGaD
Suprofen—PTGS2—Disease—NRAS—hematologic cancer	2.08e-06	5.27e-05	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.04e-06	5.19e-05	CbGpPWpGaD
Suprofen—PTGS2—Disease—MAPK3—hematologic cancer	1.99e-06	5.04e-05	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—PIK3CG—hematologic cancer	1.95e-06	4.94e-05	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—PTEN—hematologic cancer	1.95e-06	4.94e-05	CbGpPWpGaD
Suprofen—PTGS2—Disease—MYC—hematologic cancer	1.93e-06	4.91e-05	CbGpPWpGaD
Suprofen—PTGS2—Disease—TGFB1—hematologic cancer	1.93e-06	4.89e-05	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—EP300—hematologic cancer	1.86e-06	4.71e-05	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.81e-06	4.58e-05	CbGpPWpGaD
Suprofen—PTGS2—Disease—KRAS—hematologic cancer	1.79e-06	4.53e-05	CbGpPWpGaD
Suprofen—UGT1A1—Metabolism—AKT1—hematologic cancer	1.74e-06	4.4e-05	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—PIK3CA—hematologic cancer	1.73e-06	4.39e-05	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.71e-06	4.35e-05	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—ALB—hematologic cancer	1.69e-06	4.29e-05	CbGpPWpGaD
Suprofen—PTGS2—Disease—PIK3CA—hematologic cancer	1.64e-06	4.16e-05	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.62e-06	4.1e-05	CbGpPWpGaD
Suprofen—PTGS2—Disease—HRAS—hematologic cancer	1.52e-06	3.85e-05	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.49e-06	3.79e-05	CbGpPWpGaD
Suprofen—PTGS2—Disease—IL6—hematologic cancer	1.45e-06	3.69e-05	CbGpPWpGaD
Suprofen—PTGS1—Metabolism—AKT1—hematologic cancer	1.41e-06	3.59e-05	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—PIK3CA—hematologic cancer	1.37e-06	3.49e-05	CbGpPWpGaD
Suprofen—PTGS2—Disease—AKT1—hematologic cancer	1.34e-06	3.4e-05	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—PTEN—hematologic cancer	1.29e-06	3.27e-05	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—EP300—hematologic cancer	1.23e-06	3.12e-05	CbGpPWpGaD
Suprofen—PTGS2—Metabolism—AKT1—hematologic cancer	1.12e-06	2.85e-05	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—PIK3CA—hematologic cancer	9.1e-07	2.31e-05	CbGpPWpGaD
Suprofen—CYP2C9—Metabolism—AKT1—hematologic cancer	7.44e-07	1.89e-05	CbGpPWpGaD
